MedPath

Study of Pomegranate Juice in the Modulation of Oxidative Stress Markers in Endurance-based Athletes

Early Phase 1
Completed
Conditions
Oxidative Stress
Interventions
Dietary Supplement: Pomegranate juice
Registration Number
NCT02293486
Lead Sponsor
Universidad Miguel Hernandez de Elche
Brief Summary

The purpose of this study is to evaluate modifications of plasma protein carbonyls and malondialdehyde levels in endurance-based athletes after three weeks of pomegranate juice consumption.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • Perform specific endurance training sessions
  • More than 1 hour per session and more than 3 sessions per week
  • Have participated recently in a half marathon or similar event
Exclusion Criteria
  • Intake of antioxidant or anti-inflammatory supplementation
  • Present a chronic disorder
  • Non-smoker
  • No-alcoholic beverage consumption

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pomegranate Juice DilutionPomegranate juiceArm that followed all the protocols and the pomegranate juice dilution (1:1) intake.
Pomegranate JuicePomegranate juiceArm that followed all the protocols and the pomegranate juice intake.
Primary Outcome Measures
NameTimeMethod
Protein carbonyls levels changes in plasmaday 0 and 22

Protein carbonyl derivatives were determined using an adaptation of the colorimetric method published in Levine et al. (1994) based in the formation of a stable 2,4-dinitrophenyl (DNP) hydrazone product after the addition of 2,4-dinitrophenylhydrazine (DNPH) to tha plasma. Protein carbonyls were calculated as nmoles·mg-1 protein

Malondialdehyde levels changes in plasmaday 0 and 22

Malondialdehyde was determined by high pressure liquid chromatography (HPLC) with fluorescence detection according to the method described by Laporta et al. (2007). Malondialdehyde levels were calculated as nmoles·g-1 protein

Secondary Outcome Measures
NameTimeMethod
Blood biochemical parameters changes in plasmaday 0 and 22

Blood biochemical parameters is a composite outcome measure consisting in circulating plasma glucose (mg·dL-1), HDL-cholesterol (mg·dL-1), triglycerides (mg·dL-1), ferritin (ng·mL-1), lactate (mg·dL-1), sodium (mEq·L-1), potassium (mEq·L-1), creatine kinase (U·L-1), aspartate aminotransferase (U·L-1) and alanine aminotransferase (U·L-1) were analyzed through biochemistry methods.

C-reactive protein levels changes in plasmaday 0 and 22

Determination by immunoassay of C-reactive protein (ng·mL-1) levels in plasma.

Soluble E-selectin levels changes in plasmaday 0 and 22

Determination by immunoassay of soluble E-selectin (ng·mL-1) levels in plasma.

© Copyright 2025. All Rights Reserved by MedPath